Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 496

1.

Safety and Immunogenicity of the Therapeutic Vaccine TG1050 in Chronic Hepatitis B Patients: A Phase 1b Placebo-Controlled Trial.

Zoulim F, Fournier C, Habersetzer F, Sprinzl M, Pol S, Coffin CS, Leroy V, Ma M, Wedemeyer H, Lohse AW, Thimme R, Lugardon K, Martin P, Bastien B, Sansas B, Adda N, Halluard C, Bendjama K, Brandely M, Inchauspé G.

Hum Vaccin Immunother. 2019 Aug 2. doi: 10.1080/21645515.2019.1651141. [Epub ahead of print]

PMID:
31373537
2.

HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.

Ackermann C, Smits M, Woost R, Eberhard JM, Peine S, Kummer S, Marget M, Kuntzen T, Kwok WW, Lohse AW, Jacobs T, Boettler T, Schulze Zur Wiesch J.

Sci Rep. 2019 Jul 23;9(1):10624. doi: 10.1038/s41598-019-47024-8.

3.

Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.

Bernts LHP, Jones DEJ, Kaatee MM, Lohse AW, Schramm C, Sturm E, Drenth JPH.

Orphanet J Rare Dis. 2019 Jul 8;14(1):169. doi: 10.1186/s13023-019-1152-z.

4.

The Clinical Perspective on Hepatitis E.

Horvatits T, Schulze Zur Wiesch J, Lütgehetmann M, Lohse AW, Pischke S.

Viruses. 2019 Jul 5;11(7). pii: E617. doi: 10.3390/v11070617. Review.

5.

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.

Rühlemann M, Liwinski T, Heinsen FA, Bang C, Zenouzi R, Kummen M, Thingholm L, Tempel M, Lieb W, Karlsen T, Lohse A, Hov J, Denk G, Lammert F, Krawczyk M, Schramm C, Franke A.

Aliment Pharmacol Ther. 2019 Sep;50(5):580-589. doi: 10.1111/apt.15375. Epub 2019 Jun 28.

PMID:
31250469
6.

Alterations of the bile microbiome in primary sclerosing cholangitis.

Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, Schachschal G, Karlsen TH, Hov JR, Rösch T, Lohse AW, Heeren J, Franke A, Schramm C.

Gut. 2019 Jun 26. pii: gutjnl-2019-318416. doi: 10.1136/gutjnl-2019-318416. [Epub ahead of print]

PMID:
31243055
7.

Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis.

Glaser F, John C, Engel B, Höh B, Weidemann S, Dieckhoff J, Stein S, Becker N, Casar C, Amrei Schuran F, Wieschendorf B, Preti M, Jessen F, Franke A, Carambia A, Lohse AW, Ittrich H, Herkel J, Heeren J, Schramm C, Schwinge D.

J Hepatol. 2019 Jun 14. pii: S0168-8278(19)30347-2. doi: 10.1016/j.jhep.2019.05.030. [Epub ahead of print]

PMID:
31207266
8.

[Management of seasonal influenza in 2017/2018 at a German tertiary-care hospital].

Kraef C, van der Meirschen M, Wichmann D, Kutza M, Restemeyer C, Addo MM, Lohse AW, Schmiedel S, Kluge S, Schulze Zur Wiesch J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Jul;62(7):870-880. doi: 10.1007/s00103-019-02976-0. German.

PMID:
31201446
9.

Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.

Sebode M, Wigger J, Filpe P, Fischer L, Weidemann S, Krech T, Weiler-Normann C, Peiseler M, Hartl J, Tolosa E, Herkel J, Schramm C, Lohse AW, Arrenberg P.

Front Immunol. 2019 May 28;10:1065. doi: 10.3389/fimmu.2019.01065. eCollection 2019.

10.

[Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany].

Horvatits T, Drolz A, Wehmeyer M, Steib C, Trebicka J, Lohse AW, Kluwe J.

Z Gastroenterol. 2019 Jun;57(6):729-733. doi: 10.1055/a-0832-2694. Epub 2019 Jun 6. German.

PMID:
31170742
11.

A System to Determine Risk of Osteoporosis in Patients With Autoimmune Hepatitis.

Schmidt T, Schmidt C, Strahl A, Mussawy H, Rolvien T, Jandl NM, Casar C, Oheim R, Schinke T, Lohse AW, Amling M, Schramm C, Barvencik F.

Clin Gastroenterol Hepatol. 2019 Jun 1. pii: S1542-3565(19)30593-2. doi: 10.1016/j.cgh.2019.05.043. [Epub ahead of print]

PMID:
31163277
12.

No link between male infertility and HEV genotype 3 infection.

Horvatits T, Varwig-Janssen D, Schulze Zur Wiesch J, Lübke R, Reucher S, Frerk S, Addo MM, Schneider SW, Lohse AW, Luetgehetmann M, Pischke S.

Gut. 2019 May 22. pii: gutjnl-2019-319027. doi: 10.1136/gutjnl-2019-319027. [Epub ahead of print] No abstract available.

PMID:
31118248
13.

The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.

von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, Giordani MT, Schnitzler P, Bettinger D, Thimme R, Xhaard A, Binder M, Ayuk F, Lohse AW, Cornelissen JJ, de Man RA, Mallet V.

J Hepatol. 2019 Sep;71(3):465-472. doi: 10.1016/j.jhep.2019.04.022. Epub 2019 May 18.

PMID:
31108159
14.

Chronic Hepatitis E is associated with Cholangitis.

Beer A, Holzmann H, Pischke S, Behrendt P, Wrba F, Schlue J, Drebber U, Neudert B, Halilbasic E, Kreipe H, Lohse A, Sterneck M, Wedemeyer H, Manns M, Dienes HP.

Liver Int. 2019 May 18. doi: 10.1111/liv.14137. [Epub ahead of print]

PMID:
31102493
15.

Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct-Acting Antiviral Treatment Failure in Patients With Hepatitis C?

Piecha F, Gänßler JM, Jordan S, Ergen C, Ittrich H, Kluwe J, Pischke S, Lohse AW, Schulze Zur Wiesch J.

Hepatol Commun. 2019 Mar 18;3(5):614-619. doi: 10.1002/hep4.1337. eCollection 2019 May.

16.

Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors.

Schrader J, Henes FO, Blaeker M, Zimmermann-Fraedrich K, Pace A, Perez D, Izbicki JR, Lohse AW, Benten D.

Endocrine. 2019 Aug;65(2):460-467. doi: 10.1007/s12020-019-01941-w. Epub 2019 Apr 29.

PMID:
31037707
17.

Stress fractures in systemic lupus erythematosus after long-term MTX use successfully treated by MTX discontinuation and individualized bone-specific therapy.

Rolvien T, Creutzfeldt AM, Lohse AW, Amling M.

Lupus. 2019 May;28(6):790-793. doi: 10.1177/0961203319841434. Epub 2019 Apr 4.

PMID:
30947618
18.

Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study.

Pischke S, Peron JM, von Wulffen M, von Felden J, Höner Zu Siederdissen C, Fournier S, Lütgehetmann M, Iking-Konert C, Bettinger D, Par G, Thimme R, Cantagrel A, Lohse AW, Wedemeyer H, de Man R, Mallet V.

Viruses. 2019 Feb 22;11(2). pii: E186. doi: 10.3390/v11020186.

19.

Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop.

Dyson JK, De Martin E, Dalekos GN, Drenth JPH, Herkel J, Hubscher SG, Kelly D, Lenzi M, Milkiewicz P, Oo YH, Heneghan MA, Lohse AW; IAIHG Consortium.

Aliment Pharmacol Ther. 2019 Mar;49(5):528-536. doi: 10.1111/apt.15111. Epub 2019 Jan 22. Review.

PMID:
30671977
20.

Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis.

Schmidt T, Schwinge D, Rolvien T, Jeschke A, Schmidt C, Neven M, Butscheidt S, Kriz M, Kunzmann L, Mussawy H, Hubert J, Hawellek T, Rüther W, Oheim R, Barvencik F, Lohse AW, Schramm C, Schinke T, Amling M.

J Hepatol. 2019 May;70(5):941-953. doi: 10.1016/j.jhep.2018.12.035. Epub 2019 Jan 11.

PMID:
30641095
21.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for primary and secondary prophylaxis of variceal bleeding in hepatic schistosomiasis.

Kraef C, Arand J, Galaski J, Jordan S, Kluwe J, Lohse AW, Addo MM, Ramharter M, Schmiedel S.

Travel Med Infect Dis. 2019 Jul - Aug;30:130-132. doi: 10.1016/j.tmaid.2019.01.006. Epub 2019 Jan 11. No abstract available.

PMID:
30639432
22.

Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.

Pape S, Gevers TJG, Belias M, Mustafajev IF, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Hartl J, Schramm C, Lohse AW, Taubert R, Jaeckel E, Manns MP, Papp M, Stickel F, Heneghan MA, Drenth JPH.

Clin Gastroenterol Hepatol. 2019 Jan 6. pii: S1542-3565(19)30008-4. doi: 10.1016/j.cgh.2018.12.035. [Epub ahead of print]

PMID:
30625402
23.

Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis.

Jung F, Cazzagon N, Vettorazzi E, Corpechot C, Chazouilleres O, Arrivé L, Lohse AW, Schramm C, Ehlken H.

Clin Gastroenterol Hepatol. 2019 Jan 4. pii: S1542-3565(19)30006-0. doi: 10.1016/j.cgh.2018.12.033. [Epub ahead of print]

PMID:
30616025
24.

Autoimmune hepatitis: Is the autoimmunity in the family?

Sebode M, Lohse AW.

Liver Int. 2019 Jan;39(1):42-44. doi: 10.1111/liv.13989. No abstract available.

PMID:
30576081
25.

Molecular and functional heterogeneity of IL-10-producing CD4+ T cells.

Brockmann L, Soukou S, Steglich B, Czarnewski P, Zhao L, Wende S, Bedke T, Ergen C, Manthey C, Agalioti T, Geffken M, Seiz O, Parigi SM, Sorini C, Geginat J, Fujio K, Jacobs T, Roesch T, Izbicki JR, Lohse AW, Flavell RA, Krebs C, Gustafsson JA, Antonson P, Roncarolo MG, Villablanca EJ, Gagliani N, Huber S.

Nat Commun. 2018 Dec 21;9(1):5457. doi: 10.1038/s41467-018-07581-4.

26.

Response for letter "Be cautious in comparing the seroprevalence of hepatitis E detected at different years in different countries".

Horvatits T, Ozga AK, Lohse AW, Dalton HR, Pischke S.

Liver Int. 2018 Dec;38(12):2341. doi: 10.1111/liv.13915. No abstract available.

PMID:
30480377
27.

Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans.

Poetsch JH, Dahlke C, Zinser ME, Kasonta R, Lunemann S, Rechtien A, Ly ML, Stubbe HC, Krähling V, Biedenkopf N, Eickmann M, Fehling SK, Olearo F, Strecker T, Sharma P, Lang KS, Lohse AW, Schmiedel S, Becker S; VSV-Ebola Consortium (VEBCON) , Addo MM.

J Infect Dis. 2019 Jan 29;219(4):556-561. doi: 10.1093/infdis/jiy565.

28.

Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma-correlation with liver cancer and liver cirrhosis.

Nagel T, Klaus F, Ibanez IG, Wege H, Lohse A, Meyer B.

Anal Bioanal Chem. 2018 Dec;410(30):7965-7977. doi: 10.1007/s00216-018-1418-7. Epub 2018 Nov 5.

PMID:
30397756
29.

Endoscopic retrograde cholangiography and percutaneous transhepatic cholangiodrainage in biliary strictures after liver transplantation: Long-term outcome predictors and influence on patient survival.

Heinemann M, Tafrishi B, Pischke S, Fischer L, Rösch T, Lohse AW, Sterneck M, Denzer UW.

Liver Int. 2019 Jun;39(6):1155-1164. doi: 10.1111/liv.13995. Epub 2019 Feb 21.

PMID:
30367552
30.

Variant syndromes of primary biliary cholangitis.

Schulz L, Sebode M, Weidemann SA, Lohse AW.

Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:55-61. doi: 10.1016/j.bpg.2018.06.003. Epub 2018 Jun 14. Review.

PMID:
30343711
31.

Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status.

Landahl J, Bockmann JH, Scheurich C, Ackermann C, Matzat V, Heide J, Nuurei T, D'Antonio G, von Felden J, Sette A, Peine S, Lohse AW, Luetgehetmann M, Marget M, Sidney J, Schulze Zur Wiesch J.

J Infect Dis. 2019 Jan 29;219(4):568-577. doi: 10.1093/infdis/jiy549.

PMID:
30247653
32.

Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV.

Fischer T, Spohn M, Olearo F, Zinser ME, Kasonta R, Stubbe HC, Rechtien A, Ly ML, Schmiedel S, Lohse AW, Grundhoff A; VEBCON (VSV-Ebola Consortium), Addo MM, Dahlke C.

Vaccine. 2018 Nov 12;36(46):7083-7094. doi: 10.1016/j.vaccine.2018.09.016. Epub 2018 Sep 21.

PMID:
30244872
33.

Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom.

Dyson JK, Wong LL, Bigirumurame T, Hirschfield GM, Kendrick S, Oo YH, Lohse AW, Heneghan MA, Jones DEJ; UK-AIH Consortium.

Aliment Pharmacol Ther. 2018 Nov;48(9):951-960. doi: 10.1111/apt.14968. Epub 2018 Sep 18.

34.

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.

Peiseler M, Reiners D, Pinnschmidt HO, Sebode M, Jung F, Hartl J, Zenouzi R, Ehlken H, Groth S, Schachschal G, Rösch T, Weiler-Normann C, Lohse AW, Schramm C.

PLoS One. 2018 Aug 20;13(8):e0202686. doi: 10.1371/journal.pone.0202686. eCollection 2018.

35.

Lactate Improves Prediction of Short-Term Mortality in Critically Ill Patients With Cirrhosis: A Multinational Study.

Drolz A, Horvatits T, Rutter K, Landahl F, Roedl K, Meersseman P, Wilmer A, Kluwe J, Lohse AW, Kluge S, Trauner M, Fuhrmann V.

Hepatology. 2019 Jan;69(1):258-269. doi: 10.1002/hep.30151. Epub 2018 Dec 17.

PMID:
30070381
36.

Corrigendum to "Analysis of the Power of Common Diagnostic Tools in the Management of Acute Pancreatitis".

Nistal M, Zoltani M, Lohse AW, Di Daniele N, Tesauro M, Pace A.

Gastroenterol Res Pract. 2018 Jun 24;2018:4929275. doi: 10.1155/2018/4929275. eCollection 2018.

37.

Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center.

Brehm TT, Schulze Zur Wiesch J, Lütgehetmann M, Tappe D, Eisermann P, Lohse AW, Addo MM, Schmiedel S.

Infection. 2018 Dec;46(6):847-853. doi: 10.1007/s15010-018-1181-x. Epub 2018 Jul 17.

PMID:
30019313
38.

Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.

Keller S, Sedlacik J, Schuler T, Buchert R, Avanesov M, Zenouzi R, Lohse AW, Kooijman H, Fiehler J, Schramm C, Yamamura J.

Eur Radiol. 2019 Feb;29(2):818-828. doi: 10.1007/s00330-018-5614-9. Epub 2018 Jul 16.

PMID:
30014204
39.

Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study.

Grimaldi-Bensouda L, Wedemeyer H, Wiegand J, Lohse AW, Benichou J, Rossignol M, Larrey D, Abenhaim L, Poynard T, Schott E; PGRx-ALI study group.

Int J Cardiol. 2018 Sep 1;266:100-105. doi: 10.1016/j.ijcard.2018.04.007.

PMID:
29887424
40.

Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.

Kraef C, Schlein C, Hiller J, Westhölter D, Denzer U, Horvatits T, Peine S, Lohse AW, Lütgehetmann M, Polywka S, Pischke S.

J Clin Virol. 2018 Aug;105:26-30. doi: 10.1016/j.jcv.2018.05.013. Epub 2018 May 29.

PMID:
29860111
41.

Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.

Zenouzi R, Liwinski T, Yamamura J, Weiler-Normann C, Sebode M, Keller S, Lohse AW, Schramm C; International PSC Study Group (IPSCSG).

Aliment Pharmacol Ther. 2018 Jul;48(2):169-178. doi: 10.1111/apt.14797. Epub 2018 May 9.

PMID:
29741240
42.

Lack of evidence for human serum albumin as major source of HEV infections.

Horvatits T, Westhölter D, Peine S, Schulze Zur Wiesch J, Lohse AW, Lütgehetmann M, Pischke S.

Transfus Med. 2018 Dec;28(6):470-471. doi: 10.1111/tme.12536. Epub 2018 Apr 30. No abstract available.

PMID:
29707836
43.

Hepatitis E seroprevalence in the Americas: A systematic review and meta-analysis.

Horvatits T, Ozga AK, Westhölter D, Hartl J, Manthey CF, Lütgehetmann M, Rauch G, Kriston L, Lohse AW, Bendall R, Wedemeyer H, Dalton HR, Pischke S.

Liver Int. 2018 Nov;38(11):1951-1964. doi: 10.1111/liv.13859. Epub 2018 May 3.

PMID:
29660259
44.

Autoimmune hepatitis.

Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ.

Nat Rev Dis Primers. 2018 Apr 12;4:18017. doi: 10.1038/nrdp.2018.17. Review.

PMID:
29644994
45.

Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis.

Jeffery HC, Braitch MK, Bagnall C, Hodson J, Jeffery LE, Wawman RE, Wong LL, Birtwistle J, Bartlett H, Lohse AW, Hirschfield GM, Dyson J, Jones D, Hubscher SG, Klenerman P, Adams DH, Oo YH.

Hepatol Commun. 2018 Feb 26;2(4):421-436. doi: 10.1002/hep4.1163. eCollection 2018 Apr.

46.

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival.

Huebener P, Sterneck MR, Bangert K, Drolz A, Lohse AW, Kluge S, Fischer L, Fuhrmann V.

Aliment Pharmacol Ther. 2018 Jun;47(11):1502-1510. doi: 10.1111/apt.14627. Epub 2018 Apr 2.

PMID:
29611203
47.

Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology.

Marteau P, Adamsbaum C, Rossi-Semerano L, De Bandt M, Lemelle I, Deslandre C, Tran TA, Lohse A, Solau-Gervais E, Sordet C, Pillet P, Bader-Meunier B, Wipff J, Gaujoux-Viala C, Breton S, Devauchelle-Pensec V.

Eur Radiol. 2018 Sep;28(9):3963-3976. doi: 10.1007/s00330-018-5304-7. Epub 2018 Mar 26. Review.

48.

HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.

Westhölter D, Hiller J, Denzer U, Polywka S, Ayuk F, Rybczynski M, Horvatits T, Gundlach S, Blöcker J, Schulze Zur Wiesch J, Fischer N, Addo MM, Peine S, Göke B, Lohse AW, Lütgehetmann M, Pischke S.

J Hepatol. 2018 Jul;69(1):36-42. doi: 10.1016/j.jhep.2018.02.031. Epub 2018 Mar 15.

PMID:
29551705
49.

Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.

Keller S, Aigner A, Zenouzi R, Kim AC, Meijer A, Weidemann SA, Krech T, Lohse AW, Adam G, Schramm C, Yamamura J.

PLoS One. 2018 Mar 7;13(3):e0193929. doi: 10.1371/journal.pone.0193929. eCollection 2018.

50.

Disease Duration and Stage Influence Bone Microstructure in Patients With Primary Biliary Cholangitis.

Schmidt T, Schmidt C, Schmidt FN, Butscheidt S, Mussawy H, Hubert J, Hawellek T, Oehler N, Barvencik F, Lohse AW, Schinke T, Schramm C, Amling M, Rolvien T.

J Bone Miner Res. 2018 Jun;33(6):1011-1019. doi: 10.1002/jbmr.3410. Epub 2018 Mar 25.

Supplemental Content

Support Center